请使用支持JavaScript的浏览器!
主营:分子类,蛋白类,抗体类,生化类试剂
℡ 4000-520-616
℡ 4000-520-616
ubpbio/HSP70/K1301/100 µg
产品编号:K1301
市  场 价:¥4500.00
场      地:美国(厂家直采)
产品分类: 分子类>核酸酶类>连接酶>
联系QQ:1570468124
电话号码:4000-520-616
邮      箱: info@ebiomall.com
美  元  价:$225.00
品      牌: UBPBio
公司分类:
ubpbio/HSP70/K1301/100 µg
商品介绍
HSP70acriticalchaperoneproteinthathasahighaffinityforunfoldedpolypeptidechains.Itbindsextendedpeptidesegmentswithanethydrophobiccharacterexposedbypolypeptidesduringtranslationandmembranetranslocation,orfollowingstress-induceddamage.Incooperationwithotherchaperones,Hsp70stABIlizespreexistentproteinsagainstaggregationandmediatesthefoldingofnewlytranslatedpolypeptidesinthecytosolaswellaswithinorganelles.Hsp70andHsp40recruitsomemisfoldedproteinstotheubiquitinE3ligaseCHIPforubiquitination.

AdditionalInformation

Details

HSP70acriticalchaperoneproteinthathasahighaffinityforunfoldedpolypeptidechains.Itbindsextendedpeptidesegmentswithanethydrophobiccharacterexposedbypolypeptidesduringtranslationandmembranetranslocation,orfollowingstress-induceddamage.Incooperationwithotherchaperones,Hsp70stabilizespreexistentproteinsagainstaggregationandmediatesthefoldingofnewlytranslatedpolypeptidesinthecytosolaswellaswithinorganelles.Hsp70andHsp40recruitsomemisfoldedproteinstotheubiquitinE3ligaseCHIPforubiquitination.
品牌介绍

泛素-蛋白酶体生物技术有限公司(UBPBio),LLC是一家私有公司,由科学家和投资人于2011年成立。UBPBio致力于为学术界和工业界提供高质量的试剂,以加快对泛素-蛋白酶体系统及相关途径的发现。 。目前,我们的产品线包括16个类别,提供350多种产品。如果您在泛素领域需要特殊试剂,请与我们联系,我们将竭诚为您服务。 

自营商城图标
厂家直采
全球直采 正品优价
正品保障图标
正品保障
厂家直发 有线跟踪
解放采购图标
正规清关
CIF100%正规报关,提供发票
及时交付图标
及时交付
限时必达 不达必赔
ProductName:HSP70
AlsoKnownAs:HSPA1A;HSP72;HSPA1;HSP70I;HSP70-1;HSP70-1A
CatalogNo.:K1301
Size:100µg
MolecularWeight:70kDa
Species:Human
Source:Bacterialrecombinant
Stock:20mMTris,150mMNaCl,2mMβME,10%Glycerol
Concentration:Seetubelabel
QualityAssurance:~90%bySDS-PAGE,seedatasheetforgelimage
Storage:Storeat-80°C;avoidmultiplefreeze-thawcycles
PDFDataSheet:PDFDatasheetMSDS
NCBIRefSeq:NM_005345
Image(s):N/A
ShippingMethod:Dryiceshipping
References:1.Walerych.,etal.(2009)Oncogene28:4284-94
2.DaugaardM,etal.(2007)FEBSLett.581:3702-37103.KluckenJ,etal.(2006)FASEBJ.20,2050
4.FreemanBC,etal.(1995)EMBOJ14:2281-22-92